These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25933028)

  • 1. Clinical influence of early follow-up glycosylated hemoglobin levels on cardiovascular outcomes in diabetic patients with ST-segment elevation myocardial infarction after coronary reperfusion.
    Ahn J; Hong TJ; Park JS; Lee HW; Oh JH; Choi JH; Lee HC; Cha KS; Yun E; Jeong MH; Chae SC; Kim YJ; Hur SH; Seong IW; Jang YS; Cho MC; Kim CJ; Seung KB; Rha SW; Bae JH; Park SJ;
    Coron Artery Dis; 2015 Nov; 26(7):555-61. PubMed ID: 25933028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of initial glycosylated hemoglobin level on cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shin D; Ahn J; Cha KS; Park JS; Oh JH; Lee HW; Hong JY; Kim BW; Hong TJ;
    Coron Artery Dis; 2016 Jan; 27(1):40-6. PubMed ID: 26398151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients.
    Moura FA; Figueiredo VN; Teles BS; Barbosa MA; Pereira LR; Costa AP; Carvalho LS; Cintra RM; Almeida OL; Quinaglia E Silva JC; Nadruz Junior W; Sposito AC;
    Atherosclerosis; 2015 Nov; 243(1):124-30. PubMed ID: 26385505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
    BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Day-to-day fasting plasma glucose variability on the short-term prognosis of ST-segment elevation myocardial infarction: A retrospective cohort study.
    Yi M; Cao Q; Tang WH; Liu Q; Ke X
    Clin Cardiol; 2022 Dec; 45(12):1246-1254. PubMed ID: 36069119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin A1c and short-term outcomes in patients with acute myocardial infarction undergoing primary angioplasty: an observational multicenter study.
    Tian L; Zhu J; Liu L; Liang Y; Li J; Yang Y
    Coron Artery Dis; 2013 Jan; 24(1):16-22. PubMed ID: 23168569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylated hemoglobin at early follow-up and outcome in diabetic patients with ST-segment elevation myocardial infarction.
    Ndrepepa G
    Coron Artery Dis; 2015 Nov; 26(7):551-2. PubMed ID: 26401993
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of infarct-related artery vs multivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease: analysis from Korea Acute Myocardial Infarction Registry.
    Lee HW; Hong TJ; Yang MJ; An SG; Oh JH; Choi JH; Lee HC; Cha KS; Hong JY;
    Cardiol J; 2012; 19(3):256-66. PubMed ID: 22641544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin A1c is a better predictor of prognosis following the non-ST elevation acute coronary syndrome than fasting and admission glucose.
    Kmet M; Rajer B; Pernat A
    Wien Klin Wochenschr; 2014 Mar; 126(5-6):156-62. PubMed ID: 24297265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients.
    Sia CH; Chan MH; Zheng H; Ko J; Ho AF; Chong J; Foo D; Foo LL; Lim PZ; Liew BW; Chai P; Yeo TC; Tan HC; Chua T; Chan MY; Tan JWC; Bulluck H; Hausenloy DJ
    Cardiovasc Diabetol; 2021 Oct; 20(1):211. PubMed ID: 34666746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction.
    Cicek G; Uyarel H; Ergelen M; Ayhan E; Abanonu GB; Eren M; Gibson CM
    Coron Artery Dis; 2011 May; 22(3):131-7. PubMed ID: 21394027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylated hemoglobin and outcomes in diabetic patients with acute myocardial infarction after successful revascularization with stent placement: findings from the guthrie health off-label stent (GHOST) investigators.
    Singla A; Orshaw P; Boura J; Harjai KJ
    J Interv Cardiol; 2012 Jun; 25(3):262-9. PubMed ID: 22376172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a 'real world' prospective registry of the Zwolle Myocardial Infarction Study Group.
    Hermanides RS; Kennedy MW; Kedhi E; van Dijk PR; Timmer JR; Ottervanger JP; Dambrink JH; Gosselink AM; Roolvink V; Miedema K; Slingerland RJ; Koopmans P; Bilo HJ; van 't Hof AW
    Eur Heart J Acute Cardiovasc Care; 2020 Sep; 9(6):616-625. PubMed ID: 31124695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of the impact of diabetes mellitus newly diagnosed by glycated hemoglobin on outcomes in patients undergoing percutaneous coronary intervention.
    Tailakh MA; Friger M; Zahger D; Sidi A; Mazor-Dray E; Novack V
    Eur J Intern Med; 2017 Jan; 37():69-74. PubMed ID: 27665509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction.
    Zhang Q; Shen J; Zhang RY; Qiu JP; Lu JD; Zhang Y; Chen YH; Zhang JF; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Chin Med J (Engl); 2007 Nov; 120(21):1862-7. PubMed ID: 18067756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fever after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction is associated with adverse outcomes.
    Cho HO; Nam CW; Lee HM; Shin HW; Cho YK; Yoon HJ; Park HS; Kim H; Chung IS; Hur SH; Kim YN; Kim KB
    Int J Cardiol; 2014 Jan; 170(3):376-80. PubMed ID: 24290071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Hemoglobin A1c Levels in Postmenopausal Diabetic Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome.
    Lao Y; Feng L; Yuan Y; Zhang J; Huang X; Li M; Wu Z
    Med Sci Monit; 2018 Dec; 24():9399-9405. PubMed ID: 30587845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Curr Vasc Pharmacol; 2021; 19(1):91-101. PubMed ID: 32183677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.